Mike The Pike Productions (PINK: MIKP) reached up 28.57% in morning trading to $.0009 with 80M shares traded. Mike The Pike Productions is an entertainment company specializing in feature films, graphic novels and media acquisitions. Overall, MIKP projects are ‘Mainstream Independent’, combining a well-structured vision with top-tier talent; challenging current standards while maintaining mass appeal. Mike The Pike Productions (MIKP) issued an update for shareholders in the company in a continued employment of actions toward increased shareholder value in line with company growth, including settlement of debt & liabilities, reduction of authorized and outstanding shares, finalization of feature films, sales and distribution of feature films, development of feature film and graphic novel properties.
Kallo, Inc. (OTCBB: KALO) reached up 17.65% in morning trading to $.16 with 150K shares traded. Kallo, Inc., a medical information company, engages in the manufacturing and development of software that assists physicians and nurses to streamline patient information. Its software solution includes Electronic Medical Record software (EMR) and connectivity software that gathers medical information from various sources and deposits it into a single source as an electronic medical record for each patient. Kallo, Inc. (KALO) announced that the Government of Ghana has extended an invitation to Kallo to visit Accra , Ghana on the 23rd of July for final discussions for approval of distribution and operation of Kallo's Mobile Care Clinics.
Stereotaxis, Inc. (Nasdaq: STXS) reached up 16.95% in morning trading to $1.9999 with 260K shares traded. Stereotaxis is a healthcare technology and innovation leader in the development of robotic cardiology instrument navigation systems designed to enhance the treatment of arrhythmias and coronary disease, as well as information management solutions for the interventional lab. With over 100 patents for use in a hospital's interventional surgical suite, Stereotaxis helps physicians around the world provide unsurpassed patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced collaboration of life-saving information. Stereotaxis' core technologies are the Niobe® ES Remote Magnetic Navigation system, the Odyssey™ portfolio of lab optimization, networking and patient information management systems and the Vdrive™ Robotic Mechanical Navigation system and consumables. Stereotaxis, Inc. (STXS) yeseterday announced that at a Special Meeting of Stockholders, the Company's stockholders approved an amendment to the Company's Certificate of Incorporation to effect a reverse split of the Company's common stock, $0.001 par value per share, and authorized the Company's Board of Directors to determine the ratio (within a range of 1-for-4 to 1-for-10) and the effective date of the reverse stock split. The reverse stock split proposal was approved by a vote of, over 60% of the outstanding shares, and of the shares represented at the meeting, nearly 94% voted in favor of the proposal.
For a detailed quote on any of the following companies, or to read the full news articles visit PennyTrader.com
About PennyTrader.com
PennyTrader.com is a financial and investor relations website committed to covering the microcap market space including Pink Sheets and OTC Bulletin Board and sub-$5 big board stocks. We strive to provide you with the best stocks alerts in the market! We focus on OTCBB, OTC, penny stocks, sub-$5 big board stocks, and timely stocks picks and alerts. Our goal is to inform you of the HOTTEST stocks in the market before they move. Our staff has years experience in the stock market, and we are confident that you’ll be impressed with the results of our stock picks! If you wish to feature your organization on our website then you can contact us at publisher@pennytrader.com.
Disclosure: PennyTrader.com is not currently being compensated for any stocks covered in this midday report.
PennyTrader.com is not a registered investment advisers or broker/dealer. PennyTrader.com makes no recommendation that the purchase of securities of companies profiled in this press release is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the micro cap companies covered and the potential lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk. For our full disclaimer go to CLICK HERE
